Articular cartilage repair

The aim of an articular cartilage repair treatment is to restore the surface of an articular joint's hyaline cartilage. Over the last decades, surgeons and researchers have made progress in elaborating surgical cartilage repair interventions. Though these solutions do not perfectly restore articular cartilage, some of the latest technologies start to bring very promising results in repairing cartilage from traumatic injuries or chondropathies. These treatments are especially targeted by patients who suffer from articular cartilage damage. They provide pain relief while at the same time slowing down the progression of damage or considerably delaying joint replacement (knee replacement) surgery. Articular cartilage repair treatments help patients to return to their original lifestyle; regaining mobility, going back to work and even practicing sports again.

Articular cartilage repair
Specialtyorthopedic

Different articular cartilage repair procedures

Though the different articular cartilage procedures differ in the used technologies and surgical techniques, they all share the aim to repair articular cartilage whilst keeping options open for alternative treatments in the future. Broadly taken, there are five major types of articular cartilage repair:

Arthroscopic lavage / debridement

Arthroscopic lavage is a "cleaning up" procedure of the knee joint. This short term solution is not considered an articular cartilage repair procedure but rather a palliative treatment to reduce pain, mechanical restriction and inflammation. Lavage focuses on removing degenerative articular cartilage flaps and fibrous tissue. The main target group are patients with very small defects of the articular cartilage.

Marrow stimulation techniques (microfracture surgery and others)

Marrow stimulating techniques attempt to solve articular cartilage damage through an arthroscopic procedure. Firstly, damaged cartilage is drilled or punched until the underlying bone is exposed. By doing this, the subchondral bone is perforated to generate a blood clot within the defect. Studies, however, have shown that marrow stimulation techniques often have insufficiently filled the chondral defect and the repair material is often fibrocartilage (which is not as good mechanically as hyaline cartilage). The blood clot takes about 8 weeks to become fibrous tissue and it takes 4 months to become fibrocartilage. This has implications for the rehabilitation.

Further on, chances are high that after only 1 or 2 years of the surgery symptoms start to return as the fibrocartilage wears away, forcing the patient to reengage in articular cartilage repair. This is not always the case and microfracture surgery is therefore considered to be an intermediate step.

An evolvement of the microfracture technique is the implantation of a collagen membrane onto the site of the microfracture to protect and stabilize the blood clot and to enhance the chondrogenic differentiation of the MSCs. This technique is known as AMIC (Autologous Matrix-Induced Chondrogenesis) and was first published in 2003.[1]

Marrow stimulation augmented with hydrogel implant

A hydrogel implant to help the body regrow cartilage in the knee is currently being studied in U.S. and European clinical trials.[2] Called GelrinC, the implant is made of a synthetic material called polyethylene glycol (PEG) and denatured human fibrinogen protein.

During the standard microfracture procedure, the implant is applied to the cartilage defect as a liquid. It is then exposed to UVA light for 90 seconds, turning it into a solid, soft implant that completely occupies the space of the cartilage defect. The implant is designed to support the formation of hyaline cartilage through a unique guided tissue mechanism. It protects the repair site from infiltration of undesired fibrous tissue while providing the appropriate environment for hyaline cartilage matrix formation. Over six to 12 months, the implant resorbs from its surface inward, enabling it to be gradually replaced with new cartilage.[3][4][5]

Preliminary clinical studies in Europe have shown the implant improves pain and function.[6]

Marrow stimulation augmented with peripheral blood stem cells

A 2011 study reports histologically confirmed hyaline cartilage regrowth in a 5 patient case-series, 2 with grade IV bipolar or kissing lesions in the knee. The successful protocol involves arthroscopic microdrilling/ microfracture surgery followed by postoperative injections of autologous peripheral blood progenitor cells (PBPC's) and hyaluronic acid (HA).[7] PBPC’s are a blood product containing mesenchymal stem cells and is obtained by mobilizing the stem cells into the peripheral blood. Khay Yong Saw and his team propose that the microdrilling surgery creates a blood clot scaffold on which injected PBPC’s can be recruited and enhance chondrogenesis at the site of the contained lesion. They explain that the significance of this cartilage regeneration protocol is that it is successful in patients with historically difficult-to-treat grade IV bipolar or bone-on-bone osteochondral lesions.

Saw and his team are currently conducting a larger randomized trial and working towards beginning a multicenter study. The work of the Malaysian research team is gaining international attention.[8]

Osteochondral autografts and allografts

This technique/repair requires transplant sections of bone and cartilage. First, the damaged section of bone and cartilage is removed from the joint. Then a new healthy dowel of bone with its cartilage covering is punched out of the same joint and replanted into the hole left from removing the old damaged bone and cartilage. The healthy bone and cartilage are taken from areas of low stress in the joint so as to prevent weakening the joint.[9] Depending on the severity and overall size of the damage multiple plugs or dowels may be required to adequately repair the joint, which becomes difficult for osteochondral autografts. The clinical results may deteriorate over time.[10]

For osteochondral allografts, the plugs are taken from deceased donors. This has the advantage that more osteochondral tissue is available and larger damages can be repaired using either the plug (snowman) technique or by hand carving larger grafts. There are, however, worries on the histocompatibility, though no rejection drugs are required and infection has been shown to be lesser than that of a total knee or hip. Osteochondral allografting using donor cartilage has been used most historically in knees, but is also emerging in hips, ankles, shoulders and elbows. Patients are typically younger than 55, with BMI below 35, and have a desire to maintain a higher activity level that traditional joint replacements would not allow. Advances in tissue preservation and surgical technique are quickly growing this surgery in popularity.

Cell-based repairs

Aiming to obtain the best possible results, scientists have striven to replace damaged articular cartilage with healthy articular cartilage. Previous repair procedures, however, always generated fibrocartilage or, at best, a combination of hyaline and fibrocartilage repair tissue. Autologous chondrocyte implantation (ACI) procedures are cell-based repairs that aim to achieve a repair consisting of healthy articular cartilage.[11]

ACI articular cartilage repair procedures take place in three stages. First, cartilage cells are extracted arthroscopically from the patient's healthy articular cartilage that is located in a non load-bearing area of either the intercondylar notch or the superior ridge of the femoral condyles. Then these extracted cells are transferred to an in vitro environment in specialised laboratories where they grow and replicate, for approximately four to six weeks, until their population has increased to a sufficient amount. Finally, the patient undergoes a second surgery where the in vitro chondrocytes are applied to the damaged area. In this procedure, chondrocytes are injected and applied to the damaged area in combination with either a membrane or a matrix structure. These transplanted cells thrive in their new environment, forming new articular cartilage.

Autologous mesenchymal stem cell transplant

For years, the concept of harvesting stem cells and re-implanting them into one's own body to regenerate organs and tissues has been embraced and researched in animal models. In particular, mesenchymal stem cells have been shown in animal models to regenerate cartilage[1]. Recently, there has been a published case report of decrease in knee pain in a single individual using autologous mesenchymal stem cells.[2]An advantage to this approach is that a person's own stem cells are used, avoiding transmission of genetic diseases. It is also minimally invasive, minimally painful and has a very short recovery period. This alternative to the current available treatments was shown not to cause cancer in patients who were followed for 3 years after the procedure.[12]

See also Stem cell transplantation for articular cartilage repair

The importance of rehabilitation in articular cartilage repair

Rehabilitation following any articular cartilage repair procedure is paramount for the success of any articular cartilage resurfacing technique. The rehabilitation is often long and demanding. The main reason is that it takes a long time for the cartilage cells to adapt and mature into repair tissue. Cartilage is a slow adapting substance. Where a muscle takes approximately 35 weeks to fully adapt itself, cartilage only undergoes 75% adaptation in 2 years. If the rehabilitation period is too short, the cartilage repair might be put under too much stress, causing the repair to fail.

Concerns

New research by Robert Litchfield, September 2008, of the University of Western Ontario concluded that routinely practised knee surgery is ineffective at reducing joint pain or improving joint function in people with osteoarthritis. The researchers did however find that arthroscopic surgery did help a minority of patients with milder symptoms, large tears or other damage to the meniscus — cartilage pads that improve the congruence between femur and tibia bones.[13] Similarly, a 2013 Finnish study found surgery to be ineffective for knee surgery (arthroscopic partial meniscectomy), by comparing to sham treatment.[14]

gollark: Noooooooo!
gollark: It seems like Zig but somewhat worse.
gollark: GTech™ has determined that Hare literal apioform.
gollark: Last I heard fishing wasn't very intellectually engaging. I'm sure they'd be able to.
gollark: The brain has something like 100 petaflops of compute, plus or minus a few orders of magnitude.

References
  1. Behrens P., P. (2005). "Matrixgekoppelte Mikrofrakturierung". Arthroskopie. 18 (3): 193–197. doi:10.1007/s00142-005-0316-0.
  2. "Pivotal Study to Evaluate the Safety and Efficacy of GelrinC for Treatment of Cartilage Defects - Full Text View - ClinicalTrials.gov". clinicaltrials.gov. Retrieved 2019-01-23.
  3. Wechsler, Roni; Seliktar, Dror; Sarig-Nadir, Offra; Kupershmit, Ilana; Shachaf, Yonatan; Cohen, Shlomit; Goldshmid, Revital (2015-09-28). "Steric Interference of Adhesion Supports In-Vitro Chondrogenesis of Mesenchymal Stem Cells on Hydrogels for Cartilage Repair". Scientific Reports. 5: 12607. Bibcode:2015NatSR...512607G. doi:10.1038/srep12607. ISSN 2045-2322. PMC 4585928. PMID 26411496.
  4. Berdichevski, Alexandra; Shachaf, Yonatan; Wechsler, Roni; Seliktar, Dror (2015-02-01). "Protein composition alters in vivo resorption of PEG-based hydrogels as monitored by contrast-enhanced MRI". Biomaterials. 42: 1–10. doi:10.1016/j.biomaterials.2014.11.015. ISSN 0142-9612. PMID 25542788.
  5. Korner, A.; Zbyn, S.; Juras, V.; Mlynarik, V.; Ohel, K.; Trattnig, S. (2015-12-01). "Morphological and compositional monitoring of a new cell-free cartilage repair hydrogel technology â€" GelrinC by MR using semi-quantitative MOCART scoring and quantitative T2 index and new zonal T2 index calculation". Osteoarthritis and Cartilage. 23 (12): 2224–2232. doi:10.1016/j.joca.2015.07.007. ISSN 1063-4584. PMID 26187572.
  6. K.F. Almqvist, B.J. Cole, J. Bellemans, R. Arbel, E. Basad, S. Anders, S. Trattnig, A. Korner. The Treatment of Cartilage Defects of the Knee with Microfracture augmented with a Biodegradable Scaffold: Clinical Outcome. Presented at ICRS - Izmir 2013. http://www.regentis.co.il/files/files/ICRS%202013%20Cole%20.pdf
  7. Saw, KY; Anz A; Merican S; Tay YG; Ragavanaidu K; Jee CS; McGuire DA (19 Feb 2011). "Articular cartilage regeneration with autologous peripheral blood progenitor cells and hyaluronic Acid after arthroscopic subchondral drilling: a report of 5 cases with histology". Arthroscopy. 27 (4): 493–506. doi:10.1016/j.arthro.2010.11.054. PMID 21334844.
  8. Wey Wen, Lim. "Generating New Cartilage". The Star. Retrieved 6 May 2011.
  9. Gobezie R, Dubrow S. Arthroscopic total shoulder resurfacing with osteochondral allograft. J Med Ins. 2014;2014(1). doi:https://doi.org/10.24296/jomi/1
  10. Solheim E, Hegna J, Øyen J, Austgulen OK, Harlem T, Strand T. Osteochondral autografting (mosaicplasty) in articular cartilage defects in the knee: results at 5 to 9 years. Knee. 2010 Jan;17(1):84–7.
  11. Knutsen G, Drogset JO, Engebretsen L, Grøntvedt T, Isaksen V, Ludvigsen TC, Roberts S, Solheim E, Strand T, Johansen O. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am. 2007 Oct;89(10):2105–12.
  12. Centeno CJ, Schultz JR, Cheever M, Robinson B, Freeman M, Marasco W (2010). "Safety and Complications Reporting on the Re-implantation of Culture-Expanded Mesenchymal Stem Cells using Autologous Platelet Lysate Technique". Current Stem Cell Research and Therapy. 5 (1): 81–93. doi:10.2174/157488810790442796. PMID 19951252. S2CID 20901900.
  13. Therapy for arthritic knees often as effective as surgery: study
  14. Sihvonen, R.; Paavola, M.; Malmivaara, A.; Itälä, A.; Joukainen, A.; Nurmi, H.; Kalske, J.; Järvinen, T. L. N.; Finnish Degenerative Meniscal Lesion Study (FIDELITY) Group (2013). "Arthroscopic Partial Meniscectomy versus Sham Surgery for a Degenerative Meniscal Tear". New England Journal of Medicine. 369 (26): 2515–2524. doi:10.1056/NEJMoa1305189. PMID 24369076. summary
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.